AtriCure (ATRC) Enterprise Value (2010 - 2026)

AtriCure (ATRC) has 17 years of Enterprise Value data on file, last reported at -$146.2 million in Q1 2026.

• On a quarterly basis, Enterprise Value fell 46.33% year-over-year to -$146.2 million in Q1 2026; TTM through Mar 2026 was -$146.2 million, a 46.33% decrease from a year earlier, with the FY2025 full-year figure at -$167.4 million, down 36.43% from the prior year.
• Enterprise Value for Q1 2026 stood at -$146.2 million, up from -$167.4 million in the prior quarter.
• Over the last five years, Enterprise Value for ATRC reached as high as -$99.9 million in Q1 2025 and fell as low as -$167.4 million in Q4 2025.
• Historically, Enterprise Value has averaged -$127.0 million across 5 years, with a median of -$122.7 million in 2024.
• Across the five-year window, Enterprise Value soared 50.97% in 2022 and sank 46.33% in 2026, its largest moves.
• Year by year, Enterprise Value stood at -$121.1 million in 2022, then declined by 13.35% to -$137.3 million in 2023, then advanced by 10.61% to -$122.7 million in 2024, then sank by 36.43% to -$167.4 million in 2025, then climbed by 12.7% to -$146.2 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$146.2 million in Q1 2026, -$167.4 million in Q4 2025, and -$147.9 million in Q3 2025.